For the millions of adults taking antidepressants while managing cardiovascular conditions, surgical recovery, or anticoagulant therapy, a newly published expert consensus fills a long-standing clinical gap — offering the first structured decision algorithm to weigh antidepressant benefits against hemorrhagic risk in medically complex patients.
The consensus, developed by physicians affiliated with the Association of Medicine and Psychiatry following a systematic PubMed review spanning three decades of literature (1992–2024), centers on serotonin reuptake inhibitors (SRIs) — a class that includes both SSRIs and SNRIs. The mechanism behind the concern is physiological: platelets normally sequester serotonin to facilitate aggregation at wound sites, and SRIs deplete platelet serotonin stores, impairing this clotting step. The resulting consensus recommendations address initiation, dose adjustment, and discontinuation decisions specifically for patients carrying comorbid bleeding risk factors — including those on NSAIDs, anticoagulants, or with underlying coagulopathies.
The bleeding signal associated with SRIs is not new — observational research dating back to the late 1990s flagged elevated gastrointestinal and surgical bleeding rates in SRI users, and subsequent meta-analyses have broadly confirmed an elevated relative risk. What has been lacking until now is actionable, structured clinical guidance that integrates psychiatric necessity with medical risk stratification. This consensus is meaningful precisely because it operationalizes that balance into a decision algorithm rather than leaving clinicians navigating conflicting specialty guidelines. Key limitations remain: the recommendations are expert-consensus rather than derived from prospective randomized trial data, and individual bleeding risk varies substantially by drug, dose, duration, and patient biology. The guidance is also clinician-facing, underscoring that population-level risk estimates cannot substitute for individualized judgment. For the field of psychosomatic medicine, this represents a confirmatory but practically significant step toward integrated care standards.